Pharma bro Martin Shakreli was slapped on Thursday with a class action lawsuit from health insurers who claim he was engaged in a plan to create a drug monopoly that allowed him to raise the price of HIV medicine by more than 4,000 percent Got permission.
In a Manhattan federal court suit, Blue Cross and Blue Shield of Minnesota said, Shrekley – and his company Vyara Pharmaceuticals – monopolized the drug daprin in 2015, among other tactics, by “stopping competitors to obtain Darpreme samples” Launch a generic product. ”
Shkreli and his company then covered the scheme, which, according to the suit, refused to attempt to block the taking of samples in public.
With no competition, Shrekley increased the price of the drug – which is used to treat toxoplasmosis and also offered to HIV patients with compromised immune systems in 2015 – from $ 17.50 to $ 2015 in 2015. 750.
“Defenders determined that they could impose monopoly prices and obtain significant benefits at the expense of plaintiffs and class members who were forced to pay inflated prices in violation of federal retaliatory laws,” “The suit states.
Companies are seeking unspecified damages in jury trials.
Shakreli made headlines in 2015 after raising the price of a life-saving drug – and pleaded guilty to securities fraud in a defense case managed by two hedge funds.
He is currently serving a seven-year sentence following his 2017 sentence.
A former Bloomberg News reporter admitted that she made headlines back in 2020 after falling in love with Pharma Bro during a trial in her trial in Brooklyn federal court.
Christy Smyth, 38, told Elle Magazine that she “fell into a rabbit hole in her relationship with Shrebel” – and separated from her husband and moved out of her Brooklyn apartment.
Leave a Reply